EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 416 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C

Zeki KARASU ¹ , Funda YILMAZ ² , Galip ERSÖZ ³ , Fulya GÜNŞAR ⁴ , Yücel BATUR ³ , Ulus Salih AKARCA ³

Author Affiliation(s)

1.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı, İzmir

2.

Departments of Pathology, Ege University School of Medicine, İzmir

3.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji ve Mikrobiyoloji Anabilim Dalları, İzmir

4.

Departments of Gastroenterology, Ege University School of Medicine, İzmir

Turk J Gastroenterol 2001; 12: 89-94

Keywords : Chronic hepatitis B, chronic hepatitis C, interfe-ron

Read: 1337 Published: 25 July 2019

Volume 12, Issue 2, June 2001

Previous Article